Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CDTX will rise by +18.67% over the next 2 Weeks and hit $262.03 by Friday, January 2, 2026. In that time frame, CDTX's share price is expected to range between $221.43 and $300.85.
BearishAverageBullishCDTX shares rose +0.03% in Monday, December 22, 2025's trading session, rising from a previous close of $220.80 to move at $220.87. The stock demonstrated notable intraday movement (see CDTX's key stats for a full breakdown), fluctuating between $220.73 and $221.00, a +0.12% trading range. While recent weeks have seen some volatility, CDTX has managed to secure a +0.23% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.82M shares changing hands, 1.26M more than the previous session. This amounted to $400.99M in total market activity.
Will CDTX Continue Its Upward Trend?
According to analyst ratings and projections for CDTX, Cidara Therapeutics, Inc. shares are anticipated to increase by +25.99%, potentially reaching $298.44 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for CDTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the CDTX stock forecast, now is a good time to buy CDTX stock because its current trading price is -15.71% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CDTX covering social and institutional perspectives.
CDTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CDTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 83.51% to 85.15%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 78.51%, indicates significant medium-term strength. Additionally, the 100-day RSI, at 75.24%, indicates a bearish outlook for the long term. Insights into CDTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cidara Therapeutics Short-Term Forecasts
CDTX Forecast For Next 5 Days
Our algorithm anticipates Cidara Therapeutics (CDTX) stock could hit $190.96 by Dec 29, 2025. This represents a -13.54% rise from today's price, following a +0.28% change over the past five days.
CDTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cidara Therapeutics, Inc. (CDTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $209.17, which would mean a -5.30% decrease from the current price of $220.87. Projections for this period range from a high of $290.39 to a low of $118.08.
CDTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cidara Therapeutics's price over the next three months point to a drop. CDTX stock is expected to peak at $237.84 on Mar 18, 2026 after potentially dipping to $195.49 on Jan 09, 2026. On average, CDTX is likely to trade around $216.83 in the coming 90 days.
Cidara Therapeutics Stock Forecast 2025
Based on our predictive models, Cidara Therapeutics (CDTX) is expected to trade between $199.70 and $227.49 throughout 2025. This would result in an average price of $213.56, potentially offering investors a -3.31% return from current levels.
Cidara Therapeutics, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Cidara Therapeutics, Inc. (CDTX) is positioned to show a strong performance in December 2025. The price is predicted to move between $199.70 and $227.49, settling at an average of $213.56. This could translate to a -3.31% loss.
January 2026
Based on current market signals, Cidara Therapeutics, Inc. is projected to trend january 2026. We forecast a trading range from $195.49 to $230.80, with a likely average price of $214.62. Investors could expect a potential return of -2.83%.
February 2026
Our predictive algorithms indicate Cidara Therapeutics, Inc. stock may see a shift in February 2026. The expected range spans $200.92–$233.70, with an average target of $216.95. This represents a cautious outlook and a possible loss of -1.77%.
March 2026
Analyzing established trends, Cidara Therapeutics, Inc. looks set to move in March 2026. Projections place the stock between $206.06 and $237.84, averaging around $221.85. This suggests a +0.45% gain from current levels.
April 2026
Market indicators suggest Cidara Therapeutics, Inc. could experience notable changes during April 2026. Prices could fluctuate within $206.61 to $253.01, with a midpoint forecast of $232.24. The stock might deliver a +5.15% gain.
May 2026
Forecasting for May 2026, models estimate that Cidara Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $209.30 and $257.31, averaging $232.57. This signals a positive trajectory with potential returns around +5.30%.
June 2026
According to our latest forecast models, Cidara Therapeutics, Inc. (CDTX) is positioned to show a strong performance in June 2026. The price is predicted to move between $207.49 and $240.59, settling at an average of $223.25. This could translate to a +1.08% gain.
July 2026
Based on current market signals, Cidara Therapeutics, Inc. is projected to trend july 2026. We forecast a trading range from $211.02 to $244.66, with a likely average price of $226.18. Investors could expect a potential return of +2.41%.
August 2026
Our predictive algorithms indicate Cidara Therapeutics, Inc. stock may see a shift in August 2026. The expected range spans $216.45–$245.44, with an average target of $230.71. This represents a positive outlook and a possible gain of +4.46%.
September 2026
Analyzing established trends, Cidara Therapeutics, Inc. looks set to move in September 2026. Projections place the stock between $215.28 and $263.55, averaging around $242.27. This suggests a +9.69% gain from current levels.
October 2026
Market indicators suggest Cidara Therapeutics, Inc. could experience notable changes during October 2026. Prices could fluctuate within $216.33 to $269.24, with a midpoint forecast of $239.91. The stock might deliver a +8.62% gain.
November 2026
Forecasting for November 2026, models estimate that Cidara Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $216.55 and $259.82, averaging $232.77. This signals a positive trajectory with potential returns around +5.39%.
December 2026
According to our latest forecast models, Cidara Therapeutics, Inc. (CDTX) is positioned to show a strong performance in December 2026. The price is predicted to move between $218.60 and $247.43, settling at an average of $233.45. This could translate to a +5.70% gain.
CDTX's history of dividends and stock splits also plays a role in long-term investor confidence.